Kuan-Chang Lai Yi-Han Hsiao San-Chi Chen
10.3389/fimmu.2022.994064
Front Immunol
2022 Aug 31;13:994064.
pulse corticosteroid therapy immune checkpoint inhibitors immune-related adverse event nivolumab pneumonitis steroid-refractory
CC BY
https://pubmed.ncbi.nlm.nih.gov/36119082/
Antineoplastic Agents, Immunological / therapeutic use Pneumonia / chemically induced Pneumonia / diagnosis Pneumonia / drug therapy
Antineoplastic Agents, Immunological / therapeutic use Pneumonia / chemically induced Pneumonia / diagnosis Pneumonia / drug therapy Case Reports Research Support, Non-U.S. Gov't Adrenal Cortex Hormones / therapeutic use Female Humans Immune Checkpoint Inhibitors / adverse effects Immunosuppressive Agents / therapeutic use Methylprednisolone / therapeutic use Nivolumab / adverse effects Adrenal Cortex Hormones Antineoplastic Agents, Immunological Immune Checkpoint Inhibitors Immunosuppressive Agents Nivolumab Methylprednisolone
PMC9471419
36119082
Pulse corticosteroid therapy in the treatment of steroid-refractory immune checkpoint inhibitor-related pneumonitis: Case report and review
2022